Agilent Technologies will be participating in the following events:
-
3rd Win Symposium
6-8.7.2011 - Pariisi
-
The third WIN Annual Symposium is dedicated this year to a very challenging topic: Gateways to increasing the efficacy of cancer diagnostics and therapeutics. Examples questions for discussion and debate during WIN 3 include:
- Determining the efficacy of targeted cancer therapies
- Determining the efficacy of genetic and molecular biomarkers for selecting patients likely to respond to targeted therapeutics
- Improved design of clinical trials with targeted therapies. Efficient comparisons. Appropriate endpoints. Combinations of therapies. Is randomization necessary?
- Building more effective collaborations between academia, industry and patients
- Innovation in technologies that identify genetic and molecular abnormalities in cancer
- Improvements in bioinformatics and applications of systems biology
For more information about the event, go to http://www.winconsortium.org/symposium.html